AstraZeneca and Rigel Pharmaceuticals have entered an exclusive worldwide license agreement for the global development and commercialization of an investigational treatment for moderate to severe chronic asthma.
The U.S. Court of Appeals for the Federal Circuit ruled in favor of Watson Pharmaceuticals during patent litigation concerning the drug maker's abbreviated new drug application for an overactive bladder treatment.
Only about half of U.S. adults received selected preventive services — such as screenings, consultations and prescriptions — from a healthcare professional before 2010, according to a study published last week by the Centers for Disease Control and Prevention.
HealthNet on Monday released its PillManager mobile application across both Apple and Android platforms. The app allows consumers to track their own medication schedules and interact directly with their doctor or pharmacist for repeat prescriptions.